- Previous Close
19.85 - Open
18.80 - Bid 18.75 x --
- Ask 19.45 x --
- Day's Range
17.85 - 20.05 - 52 Week Range
17.40 - 27.50 - Volume
110,816 - Avg. Volume
47,986 - Market Cap (intraday)
1.102B - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
72.78 - EPS (TTM)
0.27 - Earnings Date --
- Forward Dividend & Yield 0.18 (0.89%)
- Ex-Dividend Date Aug 27, 2024
- 1y Target Est
--
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.
www.naturewise.com.twRecent News: 4732.TWO
View MorePerformance Overview: 4732.TWO
Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4732.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4732.TWO
View MoreValuation Measures
Market Cap
1.11B
Enterprise Value
628.05M
Trailing P/E
72.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.02
Price/Book (mrq)
1.75
Enterprise Value/Revenue
2.80
Enterprise Value/EBITDA
23.15
Financial Highlights
Profitability and Income Statement
Profit Margin
7.02%
Return on Assets (ttm)
0.72%
Return on Equity (ttm)
2.22%
Revenue (ttm)
224.58M
Net Income Avi to Common (ttm)
15.76M
Diluted EPS (ttm)
0.27
Balance Sheet and Cash Flow
Total Cash (mrq)
493.91M
Total Debt/Equity (mrq)
0.86%
Levered Free Cash Flow (ttm)
-21.46M